The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery

Anesthesia and Analgesia

Volumn 110, Issue 1, 2010, Pages 21-29

  Karkouti, Keyvan ^a   Wijeysundera, Duminda N ^a   Yau, Terrence M ^a   McCluskey, Stuart A ^a   Tait, Gordon ^a   Beattie, W Scott ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; FRESH FROZEN PLASMA; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; HEMOSTATIC AGENT;

ADULT; ARTICLE; BLEEDING; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; GLOMERULUS FILTRATION; HEART INFARCTION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INFECTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCORING SYSTEM; STROKE; THROMBOCYTE TRANSFUSION; AGED; COMPARATIVE STUDY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROGNOSIS; RISK; TREATMENT OUTCOME;

AGED; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COHORT STUDIES; FEMALE; HEMOSTATICS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 74049141396     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181c0ea6d     Document Type: Article

References (25)

1. Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA, Ghannam M, Yeo E, Djaiani G, Karski J. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44:1453-62
2. Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007;83: S27-86
3. Mannucci PM. Hemostatic drugs. N Engl J Med 1998;339:245-53
4. Kuitunen A, Hiippala S, Vahtera E, Rasi V, Salmenpera M. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery. Acta Anaesthesiol Scand 2005;49:1272-9
5. Day JR, Landis RC, Taylor KM. Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction. Semin Cardiothorac Vasc Anesth 2006;10:132-142
6. McEvoy MD, Reeves ST, Reves JG, Spinale FG. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action. Anesth Analg 2007;105:949-962
7. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007;356:2301-2311
8. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-365
9. Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med 2008;358:784-793
10. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 2008;358:771-783
11. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussieres JS, Cote D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358:2319-2331
12. Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera D, Fedorko L, Yau TM. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006;46:327-338
13. Wijeysundera DN, Karkouti K, Dupuis JY, Rao V, Chan CT, Granton JT, Beattie WS. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007;297:1801-1809
14. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 2007;33:409-413
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41
16. Karkouti K, Wijeysundera DN, Beattie WS, Callum JL, Cheng D, Dupuis JY, Mazer D, Rubens FD, Sawchuk C, Yau TM; Reducing Bleeding in Cardiac surgery (RBC) Research Group. Variability and predictability of blood product use in cardiac surgery: a multicentre study. Transfusion 2007;47:2081-2088
17. Ivanov J, Borger MA, Rao V, David TE. The Toronto Risk Score for adverse events following cardiac surgery. Can J Cardiol 2006;22:221-227
18. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13
19. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281
20. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol 1999;150:327-333
21. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the twenty-sixth annual SAS users group international conference. Cary, NC, 2004
22. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984;79:516-524
23. Breslow NE, Day NE. Statistical methods in cancer research. Volume I: the analysis of case-control studies. Lyon: International agency for research on cancer, 1980
24. Dietrich W. Aprotinin: 1 year on. Curr Opin Anaesthesiol 2009;22:121-127
25. Brown JR, Birkmeyer NJ, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007;115:2801-2813